Wearable sensors estimate blood oxygenation by measuring how hemoglobin in the blood absorbs light. The core technology is photoplethysmography, which uses small light-emitting diodes and a photodetector to track changes in reflected or transmitted light as blood pulses through tissue. Two wavelengths are typically used: red and infrared. Oxygenated hemoglobin absorbs these wavelengths differently than deoxygenated hemoglobin, so comparing the relative absorption at both wavelengths yields an index that correlates with arterial oxygen saturation.
How sensors and algorithms convert light into SpO2
A wearable alternates pulses of red and infrared light and records the photodetector signal. The device separates the pulsatile component tied to arterial blood from the steady background of tissue and venous blood, then forms a ratio of the alternating and steady components at each wavelength. That ratio is mapped to percent oxygen saturation using an empirical calibration curve derived from controlled experiments that compare optical signals to gold-standard arterial co-oximetry. Takuo Aoyagi, Nihon Kohden, first described the practical use of dual-wavelength oximetry, and modern wearables build on that principle while adding digital filtering, motion compensation, and machine-learning models to improve estimates. Many companies also implement reflectance sensors that read light bounced from skin rather than transmitted through a fingertip, which affects signal quality and algorithm design.
Known limitations and clinical relevance
Accuracy depends on signal quality. Factors that degrade measurements include motion, low peripheral perfusion, ambient light, skin thickness, nail polish, and skin pigmentation. The U.S. Food and Drug Administration has highlighted that these factors can affect pulse oximeter performance and advised clinicians to interpret readings in context of clinical signs. Research has documented systematic differences in how some pulse oximeters estimate saturation across racial groups, raising concerns about missed hypoxemia and unequal clinical consequences. Mary W. Sjoding, University of Michigan, reported clinically important discrepancies in arterial oxygenation that were more likely to be overlooked in patients with darker skin tones, illustrating a real-world safety issue.
These limitations have practical consequences. In healthcare settings, overreliance on a wearable reading can delay supplemental oxygen or escalation of care when saturation is overestimated. In home and community contexts, devices that underperform in certain populations can exacerbate health inequities, particularly where access to confirmatory testing is limited. Environmental and territorial realities matter: in low-resource regions, where laboratory co-oximetry and clinical staffing are scarce, reliance on consumer wearables must be tempered with awareness of their constraints.
Manufacturers and regulators continue to refine device testing and labeling to address bias and edge cases. Clinicians and users should treat wearable SpO2 as a screening tool rather than a definitive diagnostic measurement, corroborating unexpected values with clinical assessment and, when necessary, arterial blood gas or hospital-grade pulse oximetry. Practical deployment therefore blends optical physics, algorithmic calibration, regulatory oversight, and attention to social and environmental context.